Literature DB >> 31593763

Floppy eyelid syndrome: A comprehensive review.

Ricardo Salinas1, Madeleine Puig1, Constance L Fry1, Daniel A Johnson1, Ahmad Kheirkhah2.   

Abstract

Floppy eyelid syndrome (FES) is defined as eyelid hyperlaxity with reactive palpebral conjunctivitis. It is a common condition that can be associated with significant ocular irritation. FES presents with easily everted eyelids and chronic papillary conjunctivitis in the upper eyelids. It is frequently associated with ocular and systemic diseases, notably keratoconus and obstructive sleep apnea, respectively. This comprehensive review describes the epidemiology, pathological changes, proposed pathogenesis, clinical manifestations, and a variety of treatment options for this condition. Conservative treatment of FES includes aggressive lubrication, nighttime eye shield, and avoiding sleeping on the affected eye. Patients with FES and obstructive sleep apnea may have an improvement in their ocular signs and symptoms after long-term therapy with continuous positive airway pressure. In refractory cases, a corrective surgery that addresses the eyelid laxity can result in significant improvement. All patients with ocular irritation should be evaluated for the presence of FES.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31593763     DOI: 10.1016/j.jtos.2019.10.002

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  11 in total

1.  Impacts of protective face masks on ocular surface symptoms among healthcare professionals during the COVID-19 pandemic.

Authors:  Ozgur Erogul; Hamidu Hamisi Gobeka; Murat Kasikci; Leyla Eryigit Erogul; Aydin Balci
Journal:  Ir J Med Sci       Date:  2022-06-13       Impact factor: 2.089

2.  Differential effects of obstructive sleep apnea on the corneal subbasal nerve plexus and retinal nerve fiber layer.

Authors:  Katherine A Bussan; Whitney L Stuard; Natalia Mussi; Won Lee; Jess T Whitson; Yacine Issioui; Ashley A Rowe; Katherine J Wert; Danielle M Robertson
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

Review 3.  Artificial Intelligence in Predicting Systemic Parameters and Diseases From Ophthalmic Imaging.

Authors:  Bjorn Kaijun Betzler; Tyler Hyungtaek Rim; Charumathi Sabanayagam; Ching-Yu Cheng
Journal:  Front Digit Health       Date:  2022-05-26

4.  [Corneal alterations in eyelid diseases].

Authors:  Elisabeth M Messmer
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

5.  Assessment of dry eye disease in N95 versus surgical face mask wearers during COVID-19.

Authors:  Shirin Hamed Azzam; Amir Nama; Hanan Badarni; Helena Asael; Wadie Abu Dahoud; Michael Mimouni; Hiba Zayyad
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

Review 6.  Dry eye: why artificial tears are not always the answer.

Authors:  Minji Kim; Yonghoon Lee; Divy Mehra; Alfonso L Sabater; Anat Galor
Journal:  BMJ Open Ophthalmol       Date:  2021-04-08

7.  Evaluation of the Ocular Surface and Meibomian Gland in Obstructive Sleep Apnea Hypopnea Syndrome.

Authors:  Shaohua Liu; Shisheng Li; Mengmeng Li; Shiying Zeng; Baihua Chen; Liwei Zhang
Journal:  Front Med (Lausanne)       Date:  2022-02-09

8.  Is wearing a face mask associated with symptomatic dry eye disease among medical students during the COVID-19 era? An online survey.

Authors:  Wedad Al-Dolat; Luai Abu-Ismail; Almu'atasim Khamees; Noor Alqudah; Mohammed M Abukawan; Hamzeh Mohammad Alrawashdeh; Waleed Al Momani; Khaled A Kheirallah
Journal:  BMC Ophthalmol       Date:  2022-04-07       Impact factor: 2.209

9.  Assessment of the Effect of Wearing a Surgical Face Mask on Tear Film in Normal Eye Subjects.

Authors:  Mana A Alanazi; Gamal A El-Hiti; Rashid Al-Tamimi; Abdullah M Bawazir; Essam S Almutleb; Raied Fagehi; Saud A Alanazi; Ali M Masmali
Journal:  J Ophthalmol       Date:  2022-08-16       Impact factor: 1.974

10.  Floppy Eyelid Syndrome.

Authors:  Vishal Thakur; Deepa Shrestha; Aarti Bishnoi; Debajyoti Chatterjee; Valliappan Muthu; Keshavamurthy Vinay
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.